Literature DB >> 15974877

Telomere and telomerase dynamics in human cells.

W C Hahn1.   

Abstract

Accumulating evidence now implicates telomeres and telomerase as critical regulators genomic stability and replicative lifespan in mammalian cells. Disruption of telomere maintenance and/or telomerase expression contributes to the etiology of some degenerative diseases and may participate in the process of aging. Although telomere dysfunction and aberrant telomerase expression clearly play important roles in cancer development, the contribution of telomere biology to cancer is complex and involves both positive and negative influences on tumor development. Indeed, recent work from several laboratories suggests additional roles for telomeres and telomerase in both normal and malignant physiology. Understanding the complexity of telomere biology will provide further insights into chromosome biology in both normal and malignant cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15974877     DOI: 10.2174/1566524053586572

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  4 in total

Review 1.  Chromosomal telomere attrition as a mechanism for the increased risk of epithelial cancers and senescent phenotypes in type 2 diabetes.

Authors:  M J Sampson; D A Hughes
Journal:  Diabetologia       Date:  2006-06-21       Impact factor: 10.122

2.  Determination of telomerase activity in stem cells and non-stem cells of breast cancer.

Authors:  Zhi Li; Yanli He; Jiahua Zhang; Jinghui Zhang; Tao Huang
Journal:  Front Med China       Date:  2007-07

Review 3.  Molecular chaperones regulate p53 and suppress senescence programs.

Authors:  Michael Y Sherman; Michael Sherman; Vladimir Gabai; Cornelia O'Callaghan; Julia Yaglom
Journal:  FEBS Lett       Date:  2007-05-25       Impact factor: 4.124

4.  Interferon-inducible IFI16, a negative regulator of cell growth, down-regulates expression of human telomerase reverse transcriptase (hTERT) gene.

Authors:  Lynda Li Song; Larissa Ponomareva; Hui Shen; Xin Duan; Fatouma Alimirah; Divaker Choubey
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.